Neuroscience

New MS drug proves effective where others have failed

A drug which 'reboots' a person's immune system has been shown to be an effective treatment for multiple sclerosis (MS) patients who have already failed to respond to the first drug with which they were treated (a 'first-line' ...

Diseases, Conditions, Syndromes

German-Chinese coronavirus vaccine trial begins in China

Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with Chinese company Fosun Pharma, the companies said Wednesday.

Oncology & Cancer

Swapping meat for 'mycoprotein' may protect against bowel cancer

Researchers from Northumbria University have found that swapping red and processed meat for Quorn's "mycoprotein," a fungi-based meat alternative, leads to a significant reduction in intestinal genotoxins—which can cause ...

Diseases, Conditions, Syndromes

Vitreolytic ocriplasmin resolves vitreomacular traction

(HealthDay) -- Intravitreal injection of the vitreolytic agent ocriplasmin resolves vitreomacular traction and closes macular holes significantly better than placebo, but with a higher incidence of adverse events, according ...

Vaccination

Medicago and GSK to begin final Covid-19 vaccine trials

Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.

page 2 from 7